Cargando…
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
Botulinum neurotoxin type-A (BoNT/A), as onabotulinumtoxinA, is approved globally for 11 major therapeutic and cosmetic indications. While the mechanism of action for BoNT/A at the presynaptic nerve terminal has been established, questions remain regarding intracellular trafficking patterns and over...
Autores principales: | Rhéaume, Catherine, Cai, Brian B., Wang, Joanne, Fernández-Salas, Ester, Aoki, K. Roger, Francis, Joseph, Broide, Ron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516917/ https://www.ncbi.nlm.nih.gov/pubmed/26114335 http://dx.doi.org/10.3390/toxins7072354 |
Ejemplares similares
-
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
por: Mechaly, Adva, et al.
Publicado: (2022) -
Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum
por: Schümann, Friederike, et al.
Publicado: (2023) -
Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
por: Sikorra, Stefan, et al.
Publicado: (2020) -
The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
por: Lu, Bin
Publicado: (2015) -
Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A)
por: Jacky, Birgitte P. S., et al.
Publicado: (2013)